Kaitlin M. Kestenberg-Messina insider trades

Open-market stock purchases and sales by Kaitlin M. Kestenberg-Messina, COO and SVP, Compliance at Adma Biologics, Inc, from SEC Form 4 filings since Mar 31, 2024.

Recent trades

DateStockTradeValue
Jul 24, 2026ADMA Adma Biologics, IncSold (not open market)$26.6K
Apr 1, 2026ADMA Adma Biologics, IncSold (not open market)$185K
Mar 9, 2026ADMA Adma Biologics, IncSold (not open market)—
Mar 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Mar 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Mar 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Mar 9, 2026ADMA Adma Biologics, IncSold$158K
Mar 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Mar 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Mar 7, 2026ADMA Adma Biologics, IncSold (not open market)$65.2K
Mar 6, 2026ADMA Adma Biologics, IncSold (not open market)$155K
Feb 19, 2026ADMA Adma Biologics, IncSold (not open market)$133K
Feb 9, 2026ADMA Adma Biologics, IncBought (not open market)—
Feb 9, 2026ADMA Adma Biologics, IncBought (not open market)—

Companies traded

  • ADMA Adma Biologics, Inc: 2 sales, last Jul 24, 2026

Get free alerts when Kaitlin M. Kestenberg-Messina files a new trade →